Billionaire Li Ka-Shing’s Drug Maker Hutchmed Sells $608 Million Stake In Cardiovascular Joint Venture

Hutchmed, a biopharmaceutical company controlled by Hong Kong’s wealthiest person Li Ka-shing, is divesting a 45% stake in a cardiovascular joint venture for about $60…Read More